Product image of Bortezomib Medac (Bortezomib) supplied by GNH India

Bortezomib Medac

Active Ingredient:
Bortezomib
Origin:
EU

Bortezomib Medac (Bortezomib)

Bortezomib Medac is a pharmaceutical product used for intravenous administration. It is primarily utilized in the management of certain types of cancer, offering a targeted approach to treatment.

Manufacturer / TM Owner

Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Bortezomib Medac is generally used in the treatment of multiple myeloma and mantle cell lymphoma. This medication works by interfering with the growth of cancer cells, making it a valuable option for patients undergoing cancer therapy. What is Bortezomib used for? It is often prescribed as part of a comprehensive treatment plan for these specific types of cancer.

Side Effects

  • Common effects of Bortezomib Medac may include fatigue, nausea, and peripheral neuropathy. Some individuals might experience diarrhea or constipation. These effects can vary widely among users, and it is important to monitor any changes in health while using this medication.

Precautions & Warnings

  • Bortezomib Medac should be handled with care, as it is intended for intravenous use only. It is crucial to follow the administration guidelines provided by healthcare professionals to ensure safe usage. Patients should be aware of potential side effects and report any severe reactions to their healthcare provider.

Avoid Interactions

  • Bortezomib Medac may interact with other medications, particularly those that affect the liver or immune system. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness of this medication.

Frequently Asked Questions

Bortezomib Medac is primarily used in the treatment of multiple myeloma and mantle cell lymphoma.

Bortezomib Medac is administered intravenously, typically under the supervision of a healthcare professional.

Common side effects may include fatigue, nausea, peripheral neuropathy, diarrhea, and constipation.

It is important to consult a healthcare provider before combining Bortezomib Medac with other medications to avoid potential interactions.

Precautions include following administration guidelines, monitoring for side effects, and informing healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bortezomib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT